Clinical trial
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
NCT00492778 is registered in ClinicalTrials.gov with GOG Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
- Lead sponsor
- GOG Foundation
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- February 25, 2008
- Completion date
- Not reported
- Enrollment
- 165 (actual)
- Sites
- 441
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial endometrioid adenocarcinoma, variant with squamous differentiation, endometrial mucinous adenocarcinoma, endometrial squamous cell carcinoma, recurrent endometrial clear cell adenocarcinoma, recurrent endometrial endometrioid adenocarcinoma, recurrent endometrial serous adenocarcinoma, recurrent endometrial undifferentiated carcinoma, recurrent uterine corpus cancer